c-myb effects on kinetic events during MEL cell differentiation.
During dimethylsulfoxide (DMSO)-induced differentiation of Friend mouse erythroleukemia (MEL) cells there is a biphasic fall in c-myb mRNA levels. We have previously shown that constitutive expression of c-myb blocks differentiation. To delineate more accurately the point at which Myb blocks differentiation, MEL cells were transfected with a human c-myb construct under the control of the beta-globin promoter and enhancers. In concert with endogenous DMSO-induced globin transcription during MEL cell differentiation, the beta-globin c-myb transcription unit of the transfected plasmid is activated after 3-5 days of culture in media containing DMSO. Here we describe c-myb-transformed MEL clones which undergo delayed expression of the exogenous c-myb following 3-5 days of culture in DMSO. In contrast to wild-type MEL cells, both clones failed to display phenotypic markers of differentiation and continued to proliferate for up to 10 days of culture. These data suggest that the late fall in c-myb levels may be required in order for differentiation to occur. Additionally, we suggest that constitutive expression of c-myb does not block early commitment events such as activation of histone Hl', subsequent chromatin condensation, and alteration of proliferation-related gene expression. Taken together, these results show that c-myb acts very late in the process of differentiation.
Danish
R
R
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0668.
el-Awar
O
O
Weber
B L
BL
Langmore
J
J
Turka
L A
LA
Ryan
J J
JJ
Clarke
M F
MF
D000818:Animals; D015152:Blotting, Northern; D002454:Cell Differentiation / Q000235:genetics*; D002460:Cell Line; D016213:Cyclins / Q000032:analysis; D004257:DNA Polymerase II / Q000096:biosynthesis; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects; D006418:Heme / Q000096:biosynthesis; D006657:Histones / Q000096:biosynthesis; D004915:Leukemia, Erythroblastic, Acute / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D009857:Oncogenes / Q000502:physiology*; D010957:Plasmids; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis; D020598:Proto-Oncogene Proteins c-myb; D015183:Restriction Mapping; D014162:Transfection
D016213:Cyclins; D006657:Histones; D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D006418:Heme; D004257:DNA Polymerase II; D004121:Dimethyl Sulfoxide